Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Lawson Products, Inc. to Report Fourth Quarter 2020 Financial Results: https://mms.businesswire.com/media/20200206005031/en/191765/5/LP_Logo_2007_yellowbox.jpg
Lawson Products, Inc. to Report Fourth Quarter 2020 Financial Results


Lawson Products, Inc. (NASDAQ: LAWS) (“Lawson” or the “Company"), a distributor of products and services to the MRO marketplace, today announced that it will report its results for the fourth

MSG Networks Inc. Reports Fiscal 2021 Second Quarter Results
MSG Networks Inc. Reports Fiscal 2021 Second Quarter Results


MSG Networks Inc. (NYSE: MSGN) today reported financial results for the fiscal second quarter ended December 31, 2020.



Due to the COVID-19 pandemic, in March 2020, the 2019-20 NHL and NBA seasons

6 of the Top 7 Global CROs Partner With Veeva to Run Faster Clinical Trials for Sponsors
6 of the Top 7 Global CROs Partner With Veeva to Run Faster Clinical Trials for Sponsors


Veeva Systems (NYSE: VEEV) today announced that 6 out of the top 7 global CROs have joined the Veeva Vault CDMS partner program. Accelerating clinical research is a top priority in the life

Yum! Brands Reports Fourth-Quarter Results, Primed to Grow in 2021 and Beyond; Same-Store Sales Decline of (1)%, Record Digital Sales of Nearly $5 Billion: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24844/Yum!_Brands_Logo.svg.png
Yum! Brands Reports Fourth-Quarter Results, Primed to Grow in 2021 and Beyond; Same-Store Sales Decline of (1)%, Record Digital Sales of Nearly $5 Billion


Yum! Brands, Inc. (NYSE: YUM) today reported results for the fourth-quarter and year ended December 31, 2020. Fourth-quarter GAAP EPS was $1.08, a decrease of (32)%. Full-year GAAP EPS was $2.94, a

6 of the Top 7 Global CROs Partner with Veeva to Run Faster Clinical Trials for Sponsors
6 of the Top 7 Global CROs Partner with Veeva to Run Faster Clinical Trials for Sponsors


Veeva Systems (NYSE: VEEV) today announced that 6 out of the top 7 global CROs have joined the Veeva Vault CDMS partner program. Accelerating clinical research is a top priority in the life

 The New York Times Company Reports 2020 Fourth-Quarter and Full-Year Results and Announces Dividend Increase
 The New York Times Company Reports 2020 Fourth-Quarter and Full-Year Results and Announces Dividend Increase


The New York Times Company (NYSE: NYT) announced today fourth-quarter 2020 diluted earnings per share from continuing operations of $.06 compared with $.41 in the same period of 2019. Adjusted

Deciphera Pharmaceuticals, Inc. to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day
Deciphera Pharmaceuticals, Inc. to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day


Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Healthcare Talks 2021

NICE Presents Best Practices to Accelerate Leadership in CX Agility and Empower Exceptional Experiences : https://mms.businesswire.com/media/20191203005409/en/615391/5/NICE_inContact.jpg
NICE Presents Best Practices to Accelerate Leadership in CX Agility and Empower Exceptional Experiences


NICE (Nasdaq: NICE) today announced new online events showcasing strategies for ensuring exceptional experiences by empowering leadership in CX agility. With unprecedented change impacting

NuStar Energy L.P. Reports Fourth Quarter and Full-Year 2020 Earnings Results
NuStar Energy L.P. Reports Fourth Quarter and Full-Year 2020 Earnings Results


NuStar Energy L.P. (NYSE: NS) today announced its fourth quarter and full-year 2020 earnings results.



“As we came into 2020, we had just booked the best fourth quarter in company history and we

Trane Technologies Increases Dividend 11% and Authorizes New $2 Billion Share Repurchase Program
Trane Technologies Increases Dividend 11% and Authorizes New $2 Billion Share Repurchase Program


The Board of Directors of Trane Technologies plc (NYSE:TT), a global climate innovator, declared a quarterly dividend of $0.59 cents per ordinary share, or $2.36 annualized, reflecting an 11%

Ventas Named a Founding Partner for Real Estate Executive Council’s Diversity Initiative: https://mms.businesswire.com/media/20191106005316/en/282462/5/Ventas_logo.jpg
Ventas Named a Founding Partner for Real Estate Executive Council’s Diversity Initiative


Ventas, Inc., (NYSE: VTR) (“Ventas” or the “Company”) today announced a partnership with the Real Estate Executive Council’s (“REEC”) Diversity Initiative. As the “Founding Diversity Partner –

The Buckle, Inc. Reports January 2021 Net Sales: https://mms.businesswire.com/media/20191107005107/en/222882/5/buckle-logo_hex.jpg
The Buckle, Inc. Reports January 2021 Net Sales


The Buckle, Inc. (NYSE: BKE) announced today that comparable store net sales, for stores open at least one year, for the 4-week period ended January 30, 2021 increased 35.3 percent from comparable

ALLETE Board of Directors Raises Quarterly Common Stock Dividend: https://mms.businesswire.com/media/20191210005166/en/401334/5/Ace_logo.jpg
ALLETE Board of Directors Raises Quarterly Common Stock Dividend


ALLETE, Inc. (NYSE:ALE) today announced that its Board of Directors has increased the quarterly dividend on the company’s common stock to 63 cents per share, a two percent increase.



“ALLETE’s

Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across Belgium
Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across Belgium


February 4, 2021 -- Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Society of Medical Oncology (BSMO) which is running a new national pilot to evaluate the use of

Reply and Deutsche Telekom Bring Cloud-Native Networks to Life: https://mms.businesswire.com/media/20200310005095/en/778528/5/bg.jpg
Reply and Deutsche Telekom Bring Cloud-Native Networks to Life


With the launch of the Access 4.0 (A4) platform, developed in collaboration with Reply, Deutsche Telekom is breaking new ground in the construction and provision of networks. The goal of the joint

1008 Water Is Changing The Look of Hydration, Disrupting A Key Industry
1008 Water Is Changing The Look of Hydration, Disrupting A Key Industry
  • More than 1,500 studies in the US, Japan, Korea, China, Serbia, Mexico, Germany, and Slovakia highlight the health benefits of hydrogen water. 
  • Hydrogen water is gaining popularity with more than
ADVA expands industry’s smallest aggregation solution for the edge and the core
ADVA expands industry’s smallest aggregation solution for the edge and the core


ADVA (FSE: ADV) today expanded its MicroMux™ series of pluggable devices with two new models. The MicroMux™ Nano and the MicroMux™ Quattro now enable network operators to maximize the value of

GenSight Biologics Announces the Publication in Communications Biology of the Proof-of-Concept for GS030-Drug Product in Non‑Human Primates: https://mms.businesswire.com/media/20191208005050/en/761225/5/Logo+Centre+Hospitalier+XV-XX.jpg
GenSight Biologics Announces the Publication in Communications Biology of the Proof-of-Concept for GS030-Drug Product in Non‑Human Primates


Regulatory News:



GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies

ABB: Q4 and Full-Year 2020 Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23978/ABB_logo.svg.png
ABB: Q4 and Full-Year 2020 Results


ABB (SWX:ABBN): Solid end to challenging year



FOURTH QUARTER 2020 HIGHLIGHTS




  • Orders $7.0 billion, +2%; comparable -1%1


  • Revenues $7.2 billion, +2%; comparable 0%


  • Income from operations $578

TechnipFMC Announces Record and Distribution Dates for Separation into Two Industry-leading, Independent, Publicly Traded Companies: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24460/FMC_Technologies_%28logo%29.png
TechnipFMC Announces Record and Distribution Dates for Separation into Two Industry-leading, Independent, Publicly Traded Companies


Regulatory News:



TechnipFMC plc (NYSE: FTI) (Paris: FTI) (ISIN:GB00BDSFG982) today announced the timing and details regarding its previously announced separation into two industry-leading

IPA Increases Previously Announced Bought Deal Offering of Common Shares to $21.7 Million: https://mms.businesswire.com/media/20210203005983/en/857090/5/ImmunoPrecise_logo_HZ_PMS.jpg
IPA Increases Previously Announced Bought Deal Offering of Common Shares to $21.7 Million


IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today announced that, due to

ADTRAN, Inc. Reports Earnings for the Fourth Quarter of 2020 and Declares Quarterly Cash Dividend: https://mms.businesswire.com/media/20200121005937/en/37691/5/ADTRAN_high-res.jpg
ADTRAN, Inc. Reports Earnings for the Fourth Quarter of 2020 and Declares Quarterly Cash Dividend


ADTRAN, Inc. (NASDAQ: ADTN) (“ADTRAN” or the “Company”) today announced financial results for the fourth quarter of 2020. For the quarter, revenue was $130.1 million. Net income for the fourth

PulteGroup Announces Quarterly Cash Dividend of $0.14 Per Share: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24721/Pulte_Group_logo.png
PulteGroup Announces Quarterly Cash Dividend of $0.14 Per Share


PulteGroup, Inc. (NYSE: PHM) announced today that its Board of Directors has declared a quarterly cash dividend of $0.14 per common share payable April 1, 2021, to shareholders of record at the

Regis Reports Second Quarter 2021 Results and Takes Action on a Number of Initiatives to Position the Company for Growth: https://mms.businesswire.com/media/20191111005129/en/413607/5/News_Release_Logo.jpg
Regis Reports Second Quarter 2021 Results and Takes Action on a Number of Initiatives to Position the Company for Growth


Regis Corporation (NYSE: RGS):


 


 


Three Months Ended December 31,


 


Six Months Ended December 31,


(Dollars in thousands)


 


2020


 


2019


 


2020

IPA Announces $10.0 Million Bought Deal Offering of Common Shares: https://mms.businesswire.com/media/20210203005983/en/857090/5/ImmunoPrecise_logo_HZ_PMS.jpg
IPA Announces $10.0 Million Bought Deal Offering of Common Shares


IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody discovery and development, today announced that it has entered